Factor V Leiden (Arg506Gln), a Confounding Genetic Risk Factor but not Mandatory for the Occurrence of Venous Thromboembolism in Homozygotes and Obligate Heterozygotes for Cystathionine β-synthase Deficiency
暂无分享,去创建一个
[1] E. Naughten,et al. Newborn screening for homocystinuria: Irish and world experience , 1998, European Journal of Pediatrics.
[2] H. Blom,et al. Homozygous Cystathionine β-Synthase Deficiency, Combined With Factor V Leiden or Thermolabile Methylenetetrahydrofolate Reductase in the Risk of Venous Thrombosis , 1998 .
[3] J. Miletich. Thrombophilia as a multigenic disorder. , 1998, Seminars in thrombosis and hemostasis.
[4] F. Rosendaal,et al. Thrombosis in the Young: Epidemiology and Risk Factors. A Focus on Venous Thrombosis , 1997, Thrombosis and Haemostasis.
[5] L. Barness. The metabolic and molecular bases of inherited disease, 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, Vol. 3, McGraw Hill, New York, 1995, pp. 4605. , 1996 .
[6] B. Chadefaux-Vekemans,et al. Thrombophilia, homocystinuria, and mutation of the factor V gene. , 1996, The New England journal of medicine.
[7] H. Mandel,et al. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. , 1996, The New England journal of medicine.
[8] N. Dzimiri,et al. World distribution of factor V Leiden , 1996, The Lancet.
[9] P. Reitsma,et al. Factor V Leiden: An Additional Risk Factor for Thrombosis in Protein S Deficient Families? , 1995, Thrombosis and Haemostasis.
[10] B. Dahlbäck. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. , 1995, Blood.
[11] P. Reitsma,et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation , 1994, The Lancet.
[12] P. Reitsma,et al. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. , 1994, Blood.
[13] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[14] R. Clarke,et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.
[15] G. Boers,et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.
[16] K. Pettigrew,et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.
[17] N. A. Carson,et al. Homocystinuria: clinical and biochemical heterogeneity , 1982 .
[18] D. Wilcken,et al. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. , 1976, The Journal of clinical investigation.
[19] T. Perry,et al. Sulfur-containing amino acids in the plasma and urine of homocystinurics. , 1967, Clinica chimica acta; international journal of clinical chemistry.